Patent familyBCI, high confidence
Brain computer interface based pain management therapy
Filed by Kandu and Neurosolution Inc, first in 2019.
- Earliest priority
- 24 Jul 2019 · United States
- Status
- A grant was published in United States, first on 29 Jul 2025
- Published in
- United States · International (PCT) · European Patent Office · China
- Registered as
- NeuroLutions, Inc. · 神经解决方案股份有限公司
- Inventors
- Bhugra, Kern · Leuthardt, Eric C. · K·布格拉 · E·c·路德哈特
- Family
- DOCDB 72047022 · 6 publications
What it concerns
Systems, devices and methods are provided for conducting a pain management therapy session, which includes performing a BCI training session utilizing feedback to train a subject to generate defined brain signals to assist the subject in managing and/or relieving pain, and applying a stimulus to the subject, in connection with the BCI training session, at a location that is near the source of pain and/or within the nervous system pain pathway to the source of pain.
The abstract as published by the patent office, from US2021023330A1. It describes the invention; it is not a statement of what is protected.
Protection themes
Decoding
Neural decoding
What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61B2505/09, A61B5/374, A61B5/375, A61B5/377, A61B5/383). The claims define what a patent protects, and they are not read here.
Why it matters
- Decoding
- This is the step that turns brain activity into a command or a word. Its accuracy and speed are what a user experiences. The problem behind it: accuracy that holds over months without frequent recalibration, for more than one user and one task.
Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack
The family
One invention, published 6 times in 4 offices. Each publication opens in Espacenet.
- United StatesUS2021023330A128 Jan 2021US12370340B229 Jul 2025 · grantUS20260124424A17 May 2026
- International (PCT)a route to several countries, not a countryWO2021016238A128 Jan 2021
- European Patent Officea route to several countries, not a countryEP4003171A11 Jun 2022
- ChinaCN114828747A29 Jul 2022
Timeline
- 24 Jul 2019First filingEarliest priority, at United States. The family is counted in this year.
- 21 Jul 2020ApplicationsFiled at International (PCT), European Patent Office, China.
- 28 Jan 2021First publicationUS2021023330A1, United States.
- 5 Feb 2021Owner recordedUnited States, on US2021023330A1: assignment; owner named: NEUROLUTIONS, INC., CALIFORNIA.
- 8 Jul 2025ApplicationFiled at United States.
- 29 Jul 2025Grant publishedUS12370340B2, United States.
Dates as the offices published them. Office records are in the offices' own words and are a selection: refusals, lapses and withdrawals, and records that name an owner. Each concerns one member of the family, not the family as a whole, and another member in the same office may stand. Whether a patent is in force today is not assessed.
Sources
- Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
- The record itself, with its claims and description: US2021023330A1 in Espacenet
- Counted as a BCI patent family: title or abstract names the field; classified A61B5/369 (electroencephalography); filed by NeuroLutions, Inc., an organisation already in the graph; cites a family already accepted. How families are found and judged